How to Avoid Costs and Delays from FDA Import Alerts
Import alerts issued by the Food and Drug Administration mean that a company, product, or country will have goods detained at the U.S. border without physical examination until the goods are shown to be compliant by independent testing. Placement on an import alert can thus cause immense disruption, from added test costs and shipment delays to unhappy customers and lower profits. This webinar will review top-level strategies for avoiding being put on an import alert and seeking removal from an import alert.
- overview: what FDA import alerts mean and how companies are placed on them
- contractual agreements
- seeking removal from an import alert
- FSMA implications
- compliance strategies
Shelly Garg is an attorney with Sandler, Travis & Rosenberg’s Food and Drug Law Practice Group. She represents clients across a broad range of FDA-regulated product categories, including food, beverages, dietary supplements, over-the-counter drugs, medical devices, and cosmetics. She advises in strategic business planning, product development, testing and approval, labeling, advertisement and promotion, liability risk, inspections, responding to regulatory enforcement matters, and related issues. Her keen insights into the FDA and its inner workings have proven to be of significant value to her clients in successfully resolving matters before the agency.